Evidence map›Paper›PMID 21277625›Full record

ReviewThe Journal of allergy and clinical immunology2011

Future therapies for food allergies.

Anna Nowak-Węgrzyn, Hugh A Sampson

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 254 citations in OpenAlex.

  1. Oral immunotherapy for milk allergy.The Cochrane database of systematic reviews · 2012
    Pooled it
  2. Trial
  3. Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2016
    Trial
  4. Trial
  5. Trial
  6. Oral immunotherapy for treatment of egg allergy in children.The New England journal of medicine · 2012
    Trial
  7. Immunomodulatory metabolites in IgE-mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Food allergy in children-the current status and the way forward.World journal of clinical pediatrics · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Egg Allergy: Diagnosis and Immunotherapy.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Peptide and Recombinant Allergen Vaccines for Food Allergy.Clinical reviews in allergy & immunology · 2018
    Review
  20. Experimental Models for Studying Food Allergy.Cellular and molecular gastroenterology and hepatology · 2018
    Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anna Nowak-WęgrzynMount Sinai School of Medicine, Pediatric Allergy and Immunology, Jaffe Food Allergy Institute, New York, NY 10029, USA.
Hugh A Sampson
Icahn School of Medicine at Mount Sinai · US

Funding

Tolerance vs. Allergenicity; Factors Dictating Differing ResponsesU19AI044236 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2008 to 2014
$9.8M
NIAID NIH HHS U19 AI044236
6 · The paper itself

Abstract

Food allergy is an increasingly prevalent problem in westernized countries, and there is an unmet medical need for an effective form of therapy. A number of therapeutic strategies are under investigation targeting foods that most frequently provoke severe IgE-mediated anaphylactic reactions (peanut, tree nuts, and shellfish) or are most common in children, such as cow's milk and hen's egg. Approaches being pursued are both food allergen specific and nonspecific. Allergen-specific approaches include oral, sublingual, and epicutaneous immunotherapy (desensitization) with native food allergens and mutated recombinant proteins, which have decreased IgE-binding activity, coadministered within heat-killed Escherichia coli to generate maximum immune response. Diets containing extensively heated (baked) milk and egg represent an alternative approach to food oral immunotherapy and are already changing the paradigm of strict dietary avoidance for patients with food allergy. Nonspecific approaches include monoclonal anti-IgE antibodies, which might increase the threshold dose for food allergen in patients with food allergy, and a Chinese herbal formulation, which prevented peanut-induced anaphylaxis in a murine model and is currently being investigated in clinical trials. The variety of strategies for treating food allergy increases the likelihood of success and gives hope that accomplishing an effective therapy for food allergy is within reach.

Indexed as

AnimalsClinical Trials as TopicEgg HypersensitivityFood HypersensitivityHot TemperatureHumansImmunotherapyMilk

Identifiers

PMID21277625
PMCPMC3066474
OpenAlexW2033385733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.